← Back to headlines
RBC Capital Lifts PT on Nuvation Bio (NUVB) to $13 From $12 – Here’s Why
RBC Capital has increased its price target for Nuvation Bio (NUVB) from $12 to $13, citing reasons for the upward adjustment.
12 Mar, 09:39 — 12 Mar, 09:39
Sources
Showing 1 of 1 sources
